-
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank?
Tuesday, January 3, 2023 - 7:54pm | 1367Read More...Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. Here is a look at the most-searched stocks on Benzinga Pro for the month of December, ranked in order. Year-to-date values...
-
Virgin Orbit And 4 More Short Squeeze Stocks That Could Soar This Week — Including A Stock Moving Up 968 Positions
Monday, October 17, 2022 - 2:00pm | 513Read More...Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the Fintel short squeeze leaderboard. Greenwich LifeSciences: Clinical stage biopharmaceutical...
-
These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month
Friday, August 5, 2022 - 4:08pm | 1203Read More...The month of July saw $37.3 billion in trading volume for stocks that trade on the OTCQK and OTCQB. While some of the stocks that trade over-the-counter are considered penny stocks based on their share price, they are also some of the largest companies in the world and represent a diverse list...
-
5 Short Squeeze Candidates To Watch This Week: Revlon Tops The List, A SPAC Shifts To Second And More
Tuesday, June 21, 2022 - 11:58am | 575Read More...Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling. Short sellers could be looking to close out their position and can face a loss if they have to buy...
-
5 Short Squeeze Candidates To Watch This Week: 2 Former SPACs Join Leaderboard With BigBear.AI Topping List
Tuesday, May 24, 2022 - 11:17am | 620Read More...Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling. Short sellers could be looking to close out their position and can face a loss if they have to buy...
-
5 Short Squeeze Candidates To Watch: Huadi Tops List, Altimeter Group And Bit Digital Rejoin Leaderboard
Monday, November 15, 2021 - 10:28am | 612Read More...Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) or AMC Entertainment Holdings Inc (NYSE: AMC). A short squeeze can occur when a heavily shorted stock rises in value instead of falling. Short sellers could be looking to...
-
Why Cortexyme Shares Are Plunging 70% After Hours
Tuesday, October 26, 2021 - 5:55pm | 316Read More...Shares of a clinical-stage biopharmaceutical company are falling in after-hours trading Tuesday after the company shared an update. What Happened: Cortexyme Inc (NASDAQ: CRTX) reported Phase 2/3 GAIN trial data for its Alzheimer’s disease trial. The company stated co-primary endpoints were...
-
6 Biotechnology Stocks Moving In Wednesday's Pre-Market Session
Wednesday, February 5, 2020 - 8:42am | 185Read More...Gainers • Moleculin Biotech, Inc. (NASDAQ:MBRX) stock rose 35.2% to $1.19 during Wednesday's pre-market session. • Arbutus Biopharma, Inc. (NASDAQ:ABUS) shares rose 33.1% to $3.74. The most recent rating by JMP Securities, on February 05, is at Market Outperform, with a price target...
-
15 Biotechnology Stocks Moving In Thursday's After-Market Session
Friday, January 24, 2020 - 12:28am | 459Read More...Gainers • Alector, Inc. (NASDAQ:ALEC) stock rose 10.8% to $25.79 during Thursday's after-market session. The most recent rating by BTIG, on November 21, is at Buy, with a price target of $28.00. • Therapix Biosciences, Inc. (NASDAQ:TRPX) stock moved upwards by 6.1% to $0.61....
-
146 Biotechnology Stocks Moving In Thursday's Session
Thursday, January 23, 2020 - 1:47pm | 4326Read More...Gainers • Sierra Oncology, Inc. (NASDAQ:SRRA) stock increased by 3638.9% to $13.00 during Thursday's regular session. The most recent rating by Oppenheimer, on December 06, is at Outperform, with a price target of $1.20. • Innovate, Inc. (NASDAQ:INNT) stock increased by 43.1%...
-
98 Biotechnology Stocks Moving In Wednesday's Session
Wednesday, January 22, 2020 - 2:33pm | 2829Read More...Gainers • Neurotrope, Inc. (NASDAQ:NTRP) stock increased by 131.7% to $3.36 during Wednesday's regular session. • Genprex, Inc. (NASDAQ:GNPX) shares moved upwards by 51.3% to $1.74. • Trillium Therapeutics, Inc. (NASDAQ:TRIL) stock moved upwards by 31.4% to $3.64. • Aevi...
-
20 Biotechnology Stocks Moving In Tuesday's After-Market Session
Wednesday, January 22, 2020 - 12:35am | 532Read More...Gainers • Genprex, Inc. (NASDAQ:GNPX) stock increased by 18.3% to $1.36 during Tuesday's after-market session. • BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares rose 7.8% to $3.16. According to the most recent rating by Bank of America, on November 15, the current rating is at Buy...
-
Transgemonic Up Another 33% Following Yesterday's 295% Run
Friday, January 13, 2017 - 9:38am | 300Read More...Transgenomic Inc (NASDAQ: TBIO), a nano-cap biotechnology engaged in advancing personalized medicine for the detection and treatment of cancer, skyrocketed higher by 295 percent Thursday. Transgenomic's stock gained $0.84 per share Thursday and closed at $1.12 after hitting an intra-day high of $1....
-
Halozyme Achieves Endpoint In Pancreatic Cancer Study, But Not Everyone Is Bullish
Thursday, January 5, 2017 - 10:56am | 505Read More...Shares of Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company focused on developing and commercializing novel oncology products that target tumor microenvironment, gained more than 10 percent Thursday morning. Investors and traders were buying Halozyme's stock after the company...
-
4 Big Biotech Losers Heading Into The New Year
Friday, December 30, 2016 - 11:46am | 656Read More...Here is a look at some of the largest declining biotech names during the final week of 2016. Anthera Anthera Pharmaceuticals Inc (NASDAQ: ANTH) focuses on the development of products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune...
